Ranbaxy 'very disappointed' with FDA action
Decrying the US health regulator's move to ban import of drugs from its two plants, pharma major Ranbaxy on Wednesday said it had responded to every issue raised by them in the last two years. "Ranbaxy is very disappointed in the action Food and Drug Administration (FDA) has taken today," Ranbaxy said in response.
